Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Campbelltown
Clinical trial register · Australia

Clinical Trials in Campbelltown, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca3 Hoffmann-La Roche3 Novo Nordisk A/S3 Intellia Therapeutics3 Janssen Research & Development, LLC2
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Campbelltown

50 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Boehringer Ingelheim
Phase 3
270
Campbelltown, Wollongong, Ivanhoe, Nedlands
2026-12-14
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Blacktown, Campbelltown, Frankston, Hoppers Crossing, North Tamworth, Rockhampton, Wollongong
2026-08-24
Recruiting
AstraZeneca
Phase 3
600
Campbelltown, East Toowoomba, Heidelberg Heights, Parkville, St Leonards
2026-07-08
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Campbelltown, Gosford, Liverpool, Merewether, Birtinya, South Brisbane, Camberwell
2026-05-21
Active, closed
Novo Nordisk A/S
Phase 3
606
Campbelltown, Liverpool, Merewether, Adelaide
2026-04-21
Recruiting
Novo Nordisk A/S
Phase 3
1,150
Campbelltown, Liverpool, Merewether, Chelmer
2026-02-24
Recruiting
Boehringer Ingelheim
Phase 3
1,325
Campbelltown, Liverpool, New Lambton Heights, Adelaide, Box Hill, Clayton, Parkville
2026-02-17
Recruiting
AstraZeneca
Phase 3
1,100
Adelaide, Auchenflower, Campbelltown, Camperdown, Clayton, Cudgen, Garran, Gosford
2025-12-29
Recruiting
Hummingbird Bioscience
Phase 1/2
180
Campbelltown, Miranda
2025-12-17
Recruiting
Study of DONQ52 in Active Celiac Disease
NCT07239336Celiac Disease
Chugai Pharmaceutical
Phase 2
92
Campbelltown, North Sydney, Morayfield, Sippy Downs, South Brisbane, Box Hill, Parkville, Midland
2025-12-16
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Box Hill, Brisbane, Campbelltown, Heidelberg, Macquarie University, Perth, Randwick, St Albans
2025-12-12
Recruiting
Genmab
Phase 3
660
Heidelberg, Campbelltown, Camperdown, Gosford, Kingswood, Waratah, Joondalup
2025-11-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
675
Campbelltown, Frenchs Forest, Brisbane, South Brisbane, Frankston
2025-10-08
Recruiting
Bristol-Myers Squibb
Phase 2
182
Campbelltown, Camperdown, Woolloongabba, Adelaide
2025-09-09
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
NCT06960213Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2
ADARx Pharmaceuticals, Inc.
Phase 3
90
Campbelltown, Adelaide
2025-08-28
Active, closed
EIP Pharma Inc
Phase 2
90
Campbelltown, Liverpool, Birtinya, Brisbane, Southport, Box Hill, Heidelberg, Melbourne
2025-06-20
Recruiting
ROADMAP Clinical Trial
NCT06771050Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee, Large Joint Prosthetic Joint Infections
University of Newcastle, Australia
Phase 4
2,500
Garran, Bankstown, Blacktown, Campbelltown, Camperdown, Caringbah, Gateshead, Kingswood
2025-03-24
Active, closed
Astria Therapeutics, Inc.
Phase 3
157
Campbelltown, Melbourne, Murdoch
2025-03-20
Active, closed
Celgene
Phase 3
960
Campbelltown, Darlinghurst, Macquarie University, Port Macquarie, Wahroonga, Greenslopes, Southport, Adelaide
2025-03-13
Recruiting
Bristol-Myers Squibb
Phase 3
530
Campbelltown, Penrith, Brisbane, Ballarat Central, Murdoch
2025-02-25
Active, closed
Intellia Therapeutics
Phase 3
80
Campbelltown, Melbourne, Parkville
2025-01-15
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Kogarah, Campbelltown, Carlton, East Melbourne
2025-01-08
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Fitzroy, Frankston, Sunshine Coast, Campbelltown, Gosford, North Ryde, Concord
2024-11-22
By invitation
Intellia Therapeutics
Observational
100
Campbelltown
2024-04-12
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
DrugsBosutinib·Olverembatinib
Ascentage Pharma Group Inc.
Phase 3
333
Campbelltown, Liverpool, Adelaide, Perth
2024-02-05
Active, closed
Pfizer
Phase 3
394
Darlinghurst, Campbelltown, Carlton, East Melbourne, Melbourne
2024-01-19
Active, closed
Janssen Research & Development, LLC
Phase 3
774
Campbelltown, Canberra, East Melbourne, Greenslopes, Melbourne
2024-01-17
Recruiting
Amgen
Phase 3
750
Campbelltown, Concord, Kingswood, Port Macquarie, St Leonards, Waratah, Toowoomba, Woolloongabba
2023-11-16
Active, closed
Nektar Therapeutics
Phase 2
396
Darlinghurst, Kogarah, Westmead, Woolloongabba, Campbelltown, East Melbourne, Melbourne
2023-11-15
Active, closed
Pfizer
Phase 3
1,571
Phillip, Kogarah, St Leonards, Woolloongabba, Campbelltown, Woodville South, East Melbourne, Melbourne
2023-11-08
Recruiting
Inipharm Australia Pty Ltd
Phase 1
168
Camperdown, Campbelltown, Newcastle, Saint Leonards, Woolloongabba, Birtinya, Bedford Park, Box Hill
2023-09-08
Recruiting
Hoffmann-La Roche
Phase 3
420
Campbelltown, Coffs Harbour, Concord, Darlinghurst, Gosford, Auchenflower, Sippy Downs, Bendigo
2023-06-07
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Albury, Campbelltown, Camperdown, Gosford, New Lambton Heights, Saint Leonards, Wentworthville, Southport
2023-04-18
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Adelaide, Box Hill, Campbelltown, Camperdown, Clayton, Fitzroy, Heidelberg, Herston
2023-02-15
By invitation
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
NCT05396105Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II, Hereditary Angioedema Types I and II
DrugDeucrictibant
Pharvaris Netherlands B.V.
Phase 2/3
150
Campbelltown
2022-12-28
Recruiting
Gilead Sciences
Phase 3
1,514
Campbelltown, Darlinghurst, Gateshead, Port Macquarie, Cairns, Douglass, Woolloongabba, Adelaide
2022-12-12
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Adelaide, Bedford Park, Campbelltown, Chermside, Clayton, Halls Creek, Heidelberg, Melbourne
2022-02-07
Active, closed
NTLA-2002 in Adults With Hereditary Angioedema (HAE)
NCT05120830Hereditary Angioedema
Intellia Therapeutics
Phase 1/2
37
Campbelltown
2021-12-10
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Albury, Campbelltown, Liverpool, Northmead, Port Macquarie, Wollstonecraft, Auchenflower, Brisbane
2021-08-27
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Campbelltown, St Leonards, Woolloongabba
2021-05-04
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Bankstown, Campbelltown, Liverpool, South Brisbane, Adelaide, Nedlands
2021-03-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
Campbelltown, Kingswood, Waratah, Southport, Frankston, Heidelberg, St Albans
2020-12-08
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Campbelltown, Coffs Harbour, Darlinghurst, Kingswood, Kogarah, North Ryde, St Leonards, Wahroonga
2018-12-07
Recruiting
Kirby Institute
Not applicable
6,000
Canberra, Blacktown, Brookvale, Campbelltown, Cessnock, Coffs Harbour, Darlinghurst, Grafton
2018-05-28
Active, closed
University of Sydney
Phase 2
103
Campbelltown, Camperdown, Gosford, New Lambton Heights, Port Macquarie, Randwick, Saint Leonards, Wollongong
2018-02-22
Active, closed
Breast Cancer Trials, Australia and New Zealand
Not applicable
1,167
Canberra, Campbelltown, Camperdown, Darlinghurst, Gateshead, Gosford, Liverpool, Newcastle
2017-08-21
Active, closed
Canadian Cancer Trials Group
Phase 2
301
Campbelltown, Coffs Harbour, Concord, Kingswood, Kogarah, Lismore, Liverpool, Randwick
2017-03-28
Recruiting
UMC Utrecht
Phase 3
20,000
Canberra, Bankstown, Blacktown, Campbelltown, Caringbah, Concord, Dubbo, Frenchs Forest
2016-04-11
Active, closed
University of Sydney
Phase 3
802
Blacktown, Campbelltown, Camperdown, Gateshead, Gosford, Kogarah, Liverpool, Orange
2014-03
Active, closed
Trans Tasman Radiation Oncology Group
Not applicable
333
Campbelltown, Camperdown, Coffs Harbour, Darlinghurst, Kingswood, Kogarah, Liverpool, Newcastle
2009-03-03
Rows per page Showing 1–50 of 50
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/campbelltown

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 50 of those studies with a site in Campbelltown.

How many clinical trials are recruiting in Campbelltown?

23 of the 50 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 24 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Campbelltown), 50 studies
PhaseStudiesRecruitingShare
Phase 3351770%
Phase 26212%
Not applicable316%
Phase 1/2214%
Observational102%
Phase 1112%
Phase 2/3102%
Phase 4112%

Most active sponsors

Lead sponsors with the most studies (Campbelltown)
Lead sponsorStudiesRecruiting
AstraZeneca33
Hoffmann-La Roche31
Intellia Therapeutics30
Novo Nordisk A/S32
Boehringer Ingelheim21
Bristol-Myers Squibb22
Janssen Research & Development, LLC20
Karyopharm Therapeutics Inc20
Merck Sharp & Dohme LLC21
Pfizer20
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.